Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation
Glenda Nicioli da Silva Leandro Toshio Filoni; M. C Salvadori; Daisy Maria Fávero Salvadori
Pathology and Oncology Research Lausanne: Frontiers Media, 2021 v. 24, n. 2, p. 407-417
Lausanne 2018
Item não circula. Consulte sua biblioteca.(Acessar)